These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 16376465)

  • 1. Human tumor membrane vesicles modified to express glycolipid-anchored IL-12 by protein transfer induce T cell proliferation in vitro: a potential approach for local delivery of cytokines during vaccination.
    Nagarajan S; Selvaraj P
    Vaccine; 2006 Mar; 24(13):2264-74. PubMed ID: 16376465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycolipid-anchored IL-12 expressed on tumor cell surface induces antitumor immune response.
    Nagarajan S; Selvaraj P
    Cancer Res; 2002 May; 62(10):2869-74. PubMed ID: 12019166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein transfer of glycosyl-phosphatidylinositol-B7-1 into tumor cell membranes: a novel approach to tumor immunotherapy.
    McHugh RS; Nagarajan S; Wang YC; Sell KW; Selvaraj P
    Cancer Res; 1999 May; 59(10):2433-7. PubMed ID: 10344754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosomes derived from IL-12-anchored renal cancer cells increase induction of specific antitumor response in vitro: a novel vaccine for renal cell carcinoma.
    Zhang Y; Luo CL; He BC; Zhang JM; Cheng G; Wu XH
    Int J Oncol; 2010 Jan; 36(1):133-40. PubMed ID: 19956842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and characterization of glycolipid-anchored B7-1 (CD80) from baculovirus-infected insect cells: protein transfer onto tumor cells.
    Nagarajan S; Selvaraj P
    Protein Expr Purif; 1999 Nov; 17(2):273-81. PubMed ID: 10545276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation on the anti-tumor efficacy by expression of GPI-anchored mIL-21 on the surface of B16F10 cells in C57BL/6 mice.
    Zhao F; Dou J; Wang J; Chu L; Tang Q; Wang Y; Li Y; Cao M; Hu W; Hu K; Feng He X; Gu N
    Immunobiology; 2010; 215(2):89-100. PubMed ID: 19457579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation of murine B7.1-glycosylphosphatidylinositol and transmembrane-anchored staphylococcal enterotoxin. A dual-anchored tumor cell vaccine and its antitumor effect.
    Yi P; Yu H; Ma W; Wang Q; Minev BR
    Cancer; 2005 Apr; 103(7):1519-28. PubMed ID: 15739200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B7-1-HSA (CD80-CD24), a recombinant hybrid costimulatory molecule retains ligand binding and costimulatory functions.
    Wang YC; Sashidharamurthy R; Nagarajan S; Selvaraj P
    Immunol Lett; 2006 Jun; 105(2):185-92. PubMed ID: 16621031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic anti-tumor effect of glycosylphosphatidylinositol-anchored IL-2 and IL-12.
    Ji J; Li J; Holmes LM; Burgin KE; Yu X; Wagner TE; Wei Y
    J Gene Med; 2004 Jul; 6(7):777-85. PubMed ID: 15241785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic immunization with GPI-anchored anthrax protective antigen raises combined CD1d- and MHC II-restricted antibody responses by natural killer T cell-mediated help.
    Midha S; Bhatnagar R
    Vaccine; 2009 Mar; 27(11):1700-9. PubMed ID: 19195490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Glycosyl-phosphatidylinositol-anchored interleukin-2 expressed on tumor-derived exosomes induces anti-tumor immune response].
    Zhang JM; Wu XH; Zhang X; Zhang Y; Luo CL
    Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):564-9. PubMed ID: 22325213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction of expression vector of hTERT- hIL18 fusion gene and induction of cytotoxic T lymphocyte response against hTERT.
    Tong XM; Zheng SE; Bader A; Yao HP; Wu NP; Altmeyer P; Brockmeyer NH; Jin J
    Eur J Med Res; 2008 Jan; 13(1):7-14. PubMed ID: 18226991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
    Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-2/B7.1 (CD80) fusagene transduction of AML blasts by a self-inactivating lentiviral vector stimulates T cell responses in vitro: a strategy to generate whole cell vaccines for AML.
    Chan L; Hardwick N; Darling D; Galea-Lauri J; Gäken J; Devereux S; Kemeny M; Mufti G; Farzaneh F
    Mol Ther; 2005 Jan; 11(1):120-31. PubMed ID: 15585413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complete rejection of a T-cell lymphoma due to synergism of T-cell receptor costimulatory molecules, CD80, CD40L, and CD40.
    Ruybal P; Gravisaco MJ; Barcala V; Escalada A; Di Sciullo P; Waldner C; Mongini C
    Vaccine; 2008 Jan; 26(5):697-705. PubMed ID: 18155328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in Vitro.
    Cao DY; Yang JY; Dou KF; Ma LY; Teng ZH
    Hum Immunol; 2007 May; 68(5):334-41. PubMed ID: 17462500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential of CD80-transfected human breast carcinoma cells to induce peptide-specific T lymphocytes in an allogeneic human histocompatibility leukocyte antigens (HLA)-A2.1+-matched situation.
    Meyer GC; Batrla R; Rudy W; Meuer SC; Wallwiener D; Gückel B; Moebius U
    Cancer Gene Ther; 1999; 6(3):282-8. PubMed ID: 10359214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-12 requires initial CD80-mediated T-cell activation to support immune responses toward human breast and ovarian carcinoma.
    Gückel B; Meyer GC; Rudy W; Batrla R; Meuer SC; Bastert G; Wallwiener D; Moebius U
    Cancer Gene Ther; 1999; 6(3):228-37. PubMed ID: 10359208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.
    Sorensen MR; Holst PJ; Pircher H; Christensen JP; Thomsen AR
    Eur J Immunol; 2009 Oct; 39(10):2725-36. PubMed ID: 19637230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.